Expression of Prostaglandin PGE2Receptors under Conditions of Aging and Stress and the Protective Effect of the EP2 Agonist Butaprost on Retinal Ischemia-Reference-Cited by-同舟云学术

Expression of Prostaglandin PGE2Receptors under Conditions of Aging and Stress and the Protective Effect of the EP2 Agonist Butaprost on Retinal Ischemia

Published:2009-07-01 Issue:7 Volume:50 Page:3238
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Osborne Neville N.¹,Li Guang-Yu²,Ji Dan¹,Andrade da Costa Belmira L.³,Fawcett Rebecca J.¹,Kang Kui Dong¹,Rittenhouse Kay D.⁴

Affiliation:

1. From the Nuffield Laboratory of Ophthalmology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom;

2. The Second Hospital of Jilin University, Changchun, China;

3. Departmento de Fisiologia e Farmacologia, Cidade Universita´ria, Recife, PE, Brazil; and

4. Pfizer, Translation Medicine in Ophthalmology, San Diego, California.

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective effect of omidenepag on excitotoxic retinal ganglion cell death regulating COX-2–EP2–cAMP–PKA/Epac pathway via Neuron–Glia interaction;Neuroscience;2024-08

2. Pharmacological cAMP stimulation via prostaglandin receptors rescues ciliary defects in CEP290-deficient human and mouse models;2023-10-06

3. International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2Receptors (EP1–4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions;Pharmacological Reviews;2020-09-22

4. Antiglaucoma EP2Agonists: A Long Road That Led Somewhere;Journal of Ocular Pharmacology and Therapeutics;2019-11-01

5. Rostral Ventrolateral Medulla EP3 Receptor Mediates the Sympathoexcitatory and Pressor Effects of Prostaglandin E2 in Conscious Rats;Journal of Pharmacology and Experimental Therapeutics;2016-08-29